Seek medical advice promptly if you experience : Severe or persistent vomiting : This may lead to dehydration and affect blood glucose control, and could indicate gastroparesis (severe delayed gastric emptying) Severe abdominal pain : Particularly if constant, persistent, or radiating to the back, as GLP-1 receptor agonists carry a small risk of pancreatitis Right upper abdominal pain, fever or jaundice : These may indicate gallbladder problems, which can occur with GLP-1 receptor agonists Signs of dehydration : Including dark urine, dizziness, reduced urination, or extreme thirst Inability to tolerate food or fluids : This affects both nutrition and diabetes management Blood in vomit or stools : This requires immediate medical assessment Symptoms of hypoglycaemia : Particularly if taking Victoza alongside sulfonylureas or insulin For urgent concerns, contact NHS 111 or attend your local A&E department if symptoms are severe
Just listen to me
Weight loss medications differ in active ingredient, mechanism of action, dosage form, dosage, and approved use
These observations receive support of our mutagenesis studies by measuring both cAMP responses and receptor binding affinities (Fig
Dosing errors with a potent dual GIP/GLP-1 agonist carry real consequences